Related Experiment Videos
Estrogen metabolism in microsomal, cell, and tissue preparations of kidney and liver from Syrian hamsters
M A Beleh1, Y C Lin, R W Brueggemeier
1Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Ohio State University, Columbus 43210, USA.
Abstract:
The estrogen-treated golden Syrian hamster has been used as an experimental model for estrogen-induced and estrogen-dependent cancers, but pathways to neoplastic transformation remain unknown in this animal. Metabolism of estrogens to activated or reactive compounds, followed by subsequent oxidative damage to the target tissue, remains a potential step in the tumorigenic process. In this study, the extent of estrogen metabolism is compared in three different in vitro preparations from untreated and estrogen-treated Syrian hamsters, primary kidney cell cultures, microsomal preparations, and freshly prepared tissue kidney slices. In primary kidney cell cultures, the amount of catechol estrogens decreased upon increasing estrogen (DES) treatment period, and completely disappeared after about 6 months treatment. This decrease is not a result of formation of less amounts of catechol estrogens, but rather reflects the presence of the enzyme systems to further metabolize any formed catechol estrogens, since the amount of catechol estrogens formed, as detected by 3H2O release, is unchanged. The polar metabolites a, b and c increased with estrogen treatment, and metabolite c appeared only after DES treatment. The appearance of polar metabolite c only in kidney preparations from DES-treated animals implies that it may serve as a marker of cellular transformation. Estriol and estrone were detected, but were not affected by DES treatment, while no methoxyestrogens were isolated. Studies of estradiol metabolism in microsomal preparations showed a very low rate of metabolism, compared to the primary kidney cell cultures. In contrast, estrogen metabolism was extensive in kidney slices from untreated hamsters, with only approx. 30% of the substrate estradiol remaining unmetabolized after 6 h of incubation. While no catechol estrogens were detected, a small quantity of estriol, and a large amount of estrone and methoxyestrogens were isolated. The polar metabolite a was the main polar metabolite detected, with very little of metabolite b and no metabolite c. In kidney slices from 4 month DES-treated hamsters, a much higher amount of polar metabolites was detected, and metabolite c appeared after 6 h incubation. Mass spectrometric analysis and HPLC data of metabolite c indicate that this metabolite is 15 alpha-hydroxyesteradiol. This metabolite may serve as a biomarker for changes occurring in the hamster kidney cells under continuous estrogen exposure. Finally, formation of water soluble conjugates was demonstrated in both kidney slices and liver slices from Syrian hamsters, with glucuronide, sulfate and thioether conjugates of estrone and estradiol and glucuronides of catechol estrogens detected.(ABSTRACT TRUNCATED AT 400 WORDS)
Insights
Estrogen metabolism in Syrian hamsters reveals a unique metabolite, 15 alpha-hydroxyestradiol, appearing in kidney cells after prolonged diethylstilbestrol (DES) exposure, potentially marking neoplastic transformation and serving as a cancer biomarker.
Area of Science:
- Endocrinology and Cancer Research
- Metabolic pathways of steroid hormones
- Animal models for human disease
Background:
- The golden Syrian hamster model is used for studying estrogen-induced cancers, but the mechanisms of neoplastic transformation are not fully understood.
- Estrogen metabolism, potentially leading to reactive compounds and oxidative damage, is a suspected factor in estrogen-dependent tumorigenesis.
Purpose of the Study:
- To compare estrogen metabolism in different in vitro preparations from untreated and diethylstilbestrol (DES)-treated Syrian hamsters.
- To identify potential biomarkers for cellular transformation and neoplastic changes induced by estrogen exposure.
Main Methods:
- Incubation of primary kidney cell cultures, kidney slices, and microsomal preparations with estrogens.
- Analysis of estrogen metabolites using techniques such as 3H2O release, High-Performance Liquid Chromatography (HPLC), and mass spectrometry.
- Comparison of metabolic profiles between untreated and estrogen-treated (DES) hamsters.
Main Results:
- In primary kidney cell cultures, catechol estrogens decreased with prolonged DES treatment, indicating enhanced metabolism.
- A novel polar metabolite, identified as 15 alpha-hydroxyestradiol (metabolite c), appeared in kidney slices and cell cultures from DES-treated hamsters.
- Estrogen metabolism was extensive in kidney slices, with increased polar metabolites and the appearance of 15 alpha-hydroxyestradiol after DES treatment.
Conclusions:
- The formation of 15 alpha-hydroxyestradiol in hamster kidney cells under continuous estrogen exposure may serve as a biomarker for cellular transformation.
- Estrogen metabolism pathways differ significantly across various in vitro preparations.
- This study provides insights into the metabolic fate of estrogens and potential markers for estrogen-induced carcinogenesis in the hamster model.